Mr. Tarnoff joined the company in 2011 and brings nearly 30 years of pharmaceutical experience. He has built and led businesses within large pharma and biotechnology as well as early stage start-ups. His most recent roles include CEO of JDP Therapeutics, CEO of Houston Pharma (and its subsidiary Potomac Pharma), and CCO at ViroPharma. He is currently a board member of several early stage healthcare companies.

Dr. Safferstein is CEOat Cognition Therapeutics. He was VP of BD at Omrix Biopharmaceuticals, a commercial-stage company that develops and markets biosurgical and passive immunotherapy products. Prior to joining Omrix, he was Executive Vice President, Corporate Development for TransPharma Medical, a privately-held medical device company. From 2001 to 2005, Dr. Safferstein was Vice President, Business Development for Acorda Therapeutics

Dr Reiser has more than 32 years of pharmaceutical and biotech experience. He served as President, Chief Executive Officer and on the Board of CureDM Inc and was President and Chief Executive Officer and board member of Locus Pharmaceuticals, served as President, Chief Executive Officer board member at Cytogen ,Corporate Vice President, GM, and member of the Board of Directors for Berlex Laboratories, Inc

Dr. Grebow held several key positions with Cephalon, Inc. (now Teva Pharmaceuticals), a biopharmaceutical company, including Executive Vice President, Cephalon Ventures, Executive Vice President, Technical Operations, Senior Vice President, Worldwide Business Development and Senior Vice President, Drug Development. Prior to joining Cephalon, Dr. Grebow was the VP, Drug Development for Rorer Central Research, a division of RPR Pharmaceuticals Inc.

He has been the Chief Executive Officer of Scientific Health Development (SHD) since its formation in February 2006, and is a General Partner of its most recent fund. SHD is an investment fund focused on earlier stage life science companies and is located in Dallas, Texas. Prior to joining SHD, he was an attorney in private practice for over 12 years, most recently with Vinson & Elkins L.L.P. Mr. Meyer has a B.B.A. in finance.

Mr. Morris is Senior Investment Consultant to Pennsylvania Trust. He retired from Boenning & Scattergood, as a Dir and Invest Advisor for 20 years. Mr. Morris founded the Morris Investment Management Company, and has been on the boards of 20 companies.
He is trustee to The Academy of Natural Science, Lankenau Medical Ctr, Lankenau Inst of Medical Research, the Mt Desert Island Biological Laboratory, and the Wistar Inst.

Dr. Jorkasky is a highly regarded medical scientist and researcher in the pharmaceutical industry. Her experience includes positions as Head of Development and Chief Medical Officer at Endo Pharmaceuticals and Vice President of Global Clinical Research Operations. Dr. Jorkasky is board certified in internal medicine, nephrology and clinical pharmacology has published over 100 peer review articles.